[{"address1": "630 5th Avenue", "address2": "20th Floor", "city": "New York", "state": "NY", "zip": "10111", "country": "United States", "phone": "844 689 3939", "website": "https://www.anavex.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States. The company's lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome. It also provides ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer's disease. Its preclinical drug candidates include ANAVEX 1-41 for the treatment of depression, stroke, and neurogenerative disease; ANAVEX 1066 for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. Anavex Life Sciences Corp. was incorporated in 2004 and is headquartered in New York, New York.", "fullTimeEmployees": 42, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christopher U. Missling M.B.A., M.S., Ph.D.", "age": 58, "title": "President, CEO, Secretary & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 856100, "exercisedValue": 373526, "unexercisedValue": 10940450}, {"maxAge": 1, "name": "Ms. Sandra  Boenisch CPA, CGA", "age": 43, "title": "Principal Financial Officer & Treasurer", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 209527, "exercisedValue": 0, "unexercisedValue": 553580}, {"maxAge": 1, "name": "Clint  Tomlinson", "title": "VP of Corporate", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Adebayo  Laniyonu Ph.D.", "title": "Senior Vice President of Nonclinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Edward R Hammond M.D., M.P.H., Ph.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kun  Jin Ph.D.", "title": "Head of Biostatistics", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Terrie  Kellmeyer Ph.D.", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Juan Carlos  Lopez-Talavera M.D., Ph.D.", "title": "Senior VP & Head of Research and Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 4, "compensationRisk": 7, "shareHolderRightsRisk": 1, "overallRisk": 3, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.22, "open": 9.11, "dayLow": 9.096, "dayHigh": 9.61, "regularMarketPreviousClose": 9.22, "regularMarketOpen": 9.11, "regularMarketDayLow": 9.096, "regularMarketDayHigh": 9.61, "payoutRatio": 0.0, "beta": 0.67, "forwardPE": -15.015873, "volume": 370235, "regularMarketVolume": 370235, "averageVolume": 940098, "averageVolume10days": 1150240, "averageDailyVolume10Day": 1150240, "bid": 6.88, "ask": 12.1, "bidSize": 1, "askSize": 1, "marketCap": 807618240, "fiftyTwoWeekLow": 4.0, "fiftyTwoWeekHigh": 14.441, "fiftyDayAverage": 8.5472, "twoHundredDayAverage": 8.32665, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 671357504, "profitMargins": 0.0, "floatShares": 82526408, "sharesOutstanding": 85371904, "sharesShort": 25212383, "sharesShortPriorMonth": 24099499, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.2953, "heldPercentInsiders": 0.03333, "heldPercentInstitutions": 0.37672, "shortRatio": 28.32, "shortPercentOfFloat": 0.3054, "impliedSharesOutstanding": 85371904, "bookValue": 1.169, "priceToBook": 8.092386, "lastFiscalYearEnd": 1727654400, "nextFiscalYearEnd": 1759190400, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -47141000, "trailingEps": -0.56, "forwardEps": -0.63, "lastSplitFactor": "1:4", "lastSplitDate": 1444176000, "52WeekChange": 1.2324455, "SandP52WeekChange": 0.12632763, "quoteType": "EQUITY", "currentPrice": 9.46, "targetHighPrice": 46.0, "targetLowPrice": 15.0, "targetMeanPrice": 34.33333, "targetMedianPrice": 42.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 115771000, "totalCashPerShare": 1.356, "totalDebt": 0, "quickRatio": 6.699, "currentRatio": 6.739, "returnOnAssets": -0.25436002, "returnOnEquity": -0.40168998, "freeCashflow": -13688500, "operatingCashflow": -29814000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "AVXL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1751393850, "exchange": "NMS", "messageBoardId": "finmb_13580387", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Anavex Life Sciences Corp.", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 940098, "fiftyTwoWeekLowChange": 5.46, "fiftyTwoWeekLowChangePercent": 1.365, "fiftyTwoWeekRange": "4.0 - 14.441", "fiftyTwoWeekHighChange": -4.981, "fiftyTwoWeekHighChangePercent": -0.3449207, "fiftyTwoWeekChangePercent": 123.244545, "earningsTimestamp": 1747135801, "earningsTimestampStart": 1754310600, "earningsTimestampEnd": 1754656200, "earningsCallTimestampStart": 1747139400, "earningsCallTimestampEnd": 1747139400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.56, "epsForward": -0.63, "epsCurrentYear": -0.56, "priceEpsCurrentYear": -16.892857, "fiftyDayAverageChange": 0.91279984, "fiftyDayAverageChangePercent": 0.106795184, "twoHundredDayAverageChange": 1.1333504, "twoHundredDayAverageChangePercent": 0.13611121, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "regularMarketChangePercent": 2.6030343, "regularMarketPrice": 9.46, "marketState": "REGULAR", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1154525400000, "regularMarketChange": 0.23999977, "regularMarketDayRange": "9.096 - 9.61", "longName": "Anavex Life Sciences Corp.", "displayName": "Anavex Life Sciences", "trailingPegRatio": null, "__fetch_time": "2025-07-01"}]